| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |